From Data Poor to Data Rich: Alkermes Spreads the Wealth
From Data Poor to Data Rich: Alkermes Spreads the Wealth
Alkermes plc is a global biopharmaceutical company that seeks to develop innovative medicines in neuroscience. The company has a portfolio of proprietary commercial products for the treatment of alcohol dependence,
opioid dependence, schizophrenia and bipolar I disorder, and a pipeline of clinical and preclinical candidates
in development for neurological disorders, including narcolepsy. Headquartered in Ireland, Alkermes also has a corporate office and research and development center in Massachusetts and a manufacturing facility in Ohio.
Download
